World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
59144
World Ranking
4479
National Ranking
2437

Dave S.B. Hoon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dave S.B. Hoon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 487 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dave S.B. Hoon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dave S.B. Hoon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Melanoma, Cancer research, Pathology, Metastasis and Cancer are his primary areas of study. His specific area of interest is Melanoma, where Dave S.B. Hoon studies Cutaneous melanoma. The various areas that Dave S.B. Hoon examines in his Cancer research study include DNA methylation, Oncogene, Messenger RNA, microRNA and Tumor progression.

His research in Pathology intersects with topics in Colorectal cancer, Antigen, Sentinel node and Polymerase chain reaction. The study incorporates disciplines such as Sentinel lymph node, MART-1 Antigen, Lymphadenectomy, Lymph and Chemokine receptor in addition to Metastasis. His Cancer research includes themes of Gene silencing, Gene, Oncology and Bioinformatics.

His most cited work include:

  • Cell-free nucleic acids as biomarkers in cancer patients (1731 citations)
  • A landscape of driver mutations in melanoma (1701 citations)
  • Genomic Classification of Cutaneous Melanoma (1491 citations)

What are the main themes of his work throughout his whole career to date?

Dave S.B. Hoon focuses on Melanoma, Cancer research, Pathology, Cancer and Internal medicine. His studies in Melanoma integrate themes in fields like Tumor progression, Metastasis, Immunology and Immunotherapy. He interconnects DNA methylation, Molecular biology and Epigenetics, microRNA, Gene in the investigation of issues within Cancer research.

His Pathology study integrates concerns from other disciplines, such as Stage and Colorectal cancer. His Cancer research incorporates themes from Nucleic acid, DNA and Bioinformatics. His biological study spans a wide range of topics, including Endocrinology, Surgery and Oncology.

He most often published in these fields:

  • Melanoma (45.26%)
  • Cancer research (42.58%)
  • Pathology (27.01%)

What were the highlights of his more recent work (between 2014-2021)?

  • Cancer research (42.58%)
  • Melanoma (45.26%)
  • Cancer (26.76%)

In recent papers he was focusing on the following fields of study:

His main research concerns Cancer research, Melanoma, Cancer, DNA methylation and Internal medicine. His Cancer research research is multidisciplinary, incorporating elements of Cell growth, Immune system and Regulation of gene expression, Epigenetics, Gene. The Melanoma study combines topics in areas such as Pathology, Metastasis, Brain metastasis and Immunotherapy.

The study incorporates disciplines such as Blockade, Biopsy and Immunology in addition to Cancer. His studies in DNA methylation integrate themes in fields like Chromatin and Methylation. His Internal medicine study deals with Oncology intersecting with Biomarker, Cohort, Disease and Urine.

Between 2014 and 2021, his most popular works were:

  • Genomic Classification of Cutaneous Melanoma (1491 citations)
  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma (543 citations)
  • Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA (393 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Dave S.B. Hoon spends much of his time researching Cancer research, Melanoma, Cancer, Gene and Oncology. His Cancer research research incorporates themes from DNA methylation, Carcinogenesis, Immune system, microRNA and Drug resistance. He studies Cutaneous melanoma, a branch of Melanoma.

His research in Cancer intersects with topics in Biopsy, Immunology and DNA sequencing. His Gene research entails a greater understanding of Genetics. His Oncology study combines topics from a wide range of disciplines, such as Missense mutation, Colon adenocarcinoma, Pathology and Biomarker, Internal medicine.

Best Publications

  • Cell-free nucleic acids as biomarkers in cancer patients

    Heidi Schwarzenbach;Dave S. B. Hoon;Klaus Pantel

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • A landscape of driver mutations in melanoma

    Eran Hodis;Ian R. Watson;Ian R. Watson;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov;Stefan T. Arold

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    Mark B. Faries;John F. Thompson;Alistair J. Cochran;Robert H. Andtbacka

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA

    Richard B. Lanman;Stefanie A. Mortimer;Oliver A. Zill;Dragan Sebisanovic

  • Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer

    Sota Asaga;Christine Kuo;Tung Nguyen;Marilou Terpenning

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.

    D. S. B. Hoon;Yuan Wang;P. S. Dale;A. J. Conrad

  • Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

    Peter J. Bostick;Sunanda Chatterjee;Dorcas D. Chi;Kelly T. Huynh

  • Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in Serum

    Naoyuki Umetani;Armando E. Giuliano;Suzanne H. Hiramatsu;Farin Amersi

  • Chemokine Receptor CXCR4 Expression in Colorectal Cancer Patients Increases the Risk for Recurrence and for Poor Survival

    Joseph Kim;Hiroya Takeuchi;Stella T. Lam;Roderick R. Turner

  • Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

    D L Morton;L J Foshag;D S Hoon;J A Nizze

  • Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment

    Yusuke Sato;Yasufumi Goto;Norihiko Narita;Dave S.B. Hoon

  • Increased Integrity of Free Circulating DNA in Sera of Patients with Colorectal or Periampullary Cancer: Direct Quantitative PCR for ALU Repeats

    Naoyuki Umetani;Joseph Kim;Suzanne Hiramatsu;Howard A. Reber

  • Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.

    Donald L. Morton;Dave S.B. Hoon;Alistair J. Cochran;Roderick R. Turner

Frequent Co-Authors

Donald L. Morton
Donald L. Morton Saint John's Health Center
Armando E. Giuliano
Armando E. Giuliano Cedars-Sinai Medical Center
He-Jing Wang
He-Jing Wang University of California, Los Angeles
David Elashoff
David Elashoff University of California, Los Angeles
Steven J. O'Day
Steven J. O'Day St. John's University
Richard A. Scolyer
Richard A. Scolyer Royal Prince Alfred Hospital
Alistair J. Cochran
Alistair J. Cochran University of California, Los Angeles
Robert Elashoff
Robert Elashoff University of California, Los Angeles
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
James S. Wilmott
James S. Wilmott University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA is no longer limited to traditional, in-person programs. Many students are now exploring online degrees that offer flexibility, affordability, and diverse entry points—especially in nursing. If you’re considering advancing your nursing credentials while managing other responsibilities, online options provide a practical solution.

For those seeking advanced practice and leadership roles, there are cheapest dnp programs online that deliver high-quality education at a lower cost. Registered Nurses can also boost their qualifications without leaving their jobs through cheapest accredited online rn to bsn programs.

If you hold a non-nursing bachelor’s degree but want to transition into nursing, consider direct entry msn programs that get you started quickly. Additionally, students seeking a smoother admission path into nursing school may prefer direct admit nursing programs.

These online and direct admission pathways open doors to rewarding healthcare careers, accommodating varied backgrounds and goals.

Best Scientists Citing Dave S.B. Hoon

Trending Scientists